story of the week
Efficacy and Safety of Low-Dose Spironolactone for CKD in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Clinical Endocrinology and Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of low-dose spironolactone for chronic kidney disease in type 2 diabetes
J. Clin. Endocrinol. Metab. 2023 Mar 14;[EPub Ahead of Print], A Oiwa, D Hiwatashi, T Takeda, T Miyamoto, I Kawata, M Koinuma, M Yamazaki, M KomatsuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.